← Open Payments lookup

REBA MAHAFFEY: Open Payments

NPI 1215072715 · RENSSELAER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$297 in 10 payments from 6 companies in 2025. Trend: 2023 $445 · 2024 $431 · 2025 $297

Food & beverage: $297
CompanyPaymentsAmount
ARGENX US, INC.4$167
ABBVIE INC.2$31
Octapharma USA, Inc.1$29
Takeda Pharmaceuticals U.S.A., Inc.1$28
SpringWorks Therapeutics, Inc.1$22
Genentech USA, Inc.1$20

Products named: VYVGART, UBRELVY, PANZYGA, VYVGART HYTRULO, HYQVIA, GOMEKLI, Ocrevus Zunovo.

Industry payments across IN — which companies pay providers there.